(Total Views: 614)
Posted On: 05/22/2020 10:41:07 AM
Post# of 151807
WebMD:
Excerpt:
The Washington state-based biotech firm CytoDyn is preparing a clinical trial that would combine remdesivir with leronlimab, a drug that inhibits viral infection and also has shown some anti-inflammatory effects, the company announced this week.
https://www.webmd.com/lung/news/20200521/comb...reatment#1
Excerpt:
The Washington state-based biotech firm CytoDyn is preparing a clinical trial that would combine remdesivir with leronlimab, a drug that inhibits viral infection and also has shown some anti-inflammatory effects, the company announced this week.
https://www.webmd.com/lung/news/20200521/comb...reatment#1
(0)
(0)Scroll down for more posts ▼
